Precision medicine market
Precision Medicine Market, By Application (Oncology, Central Nervous System, Hematology , Immunology , Respiratory , and Others), By Technology (Bioinformatics, Gene Sequencing, Precision Molecular Diagnostics, Big Data Analytics, and Others), By End User (Biopharmaceutical Companies, Diagnostic Laboratories, Academic & Research Institutions, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
- Mar 2024
- CMI145
- 170 Pages
- Excel & Pdf
- Pharmaceutical
Summary
N/A
Table of Content
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Acquisitions and Partnerships Scenario
- Ongoing Developments
- Porter’s Analysis
- PEST Analysis
- Global Precision Medicine Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
- Global Precision Medicine Market, By Technology, 2019 – 2031, (US$ Billion)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Bioinformatics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Gene Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Drug Discovery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Precision Molecular Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Big Data Analytics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Overview
- Global Precision Medicine Market, By Application, 2019 – 2031, (US$ Billion)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Others
- Central Nervous System
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Hematology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Immunology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Respiratory
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Overview
- Global Precision Medicine Market, By Region, 2019 – 2031, (US$ Billion)
-
-
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019–2031
- Regional Trends
-
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (US$ Billion)
- North Africa
- Central Africa
- South Africa
-
- Competitive Landscape
- Intomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GENinCode
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NanoString
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Tepnel Pharma Services Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- QIAGEN
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Quest Diagnostics Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Laboratory Corporation of America Holdings
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- bioMérieux SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategie
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eli Lilly & Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cepheid
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Myriad Genetics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Intomics
- Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
Segmentation
Market Segmentation
- Technology:
- Bioinformatics
- Gene Sequencing
- Precision Molecular Diagnostics
- Big Data Analytics
- Others
- Application:
- Oncology
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Others
- Central Nervous System
- Hematology
- Immunology
- Respiratory
- Others
- Oncology
- End User:
- Biopharmaceutical Companies
- Diagnostic Laboratories
- Academic & Research Institutions
- Others
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Frequently Asked Questions -
What will be the CAGR of the precision medicine market?
The CAGR of the precision medicine market is projected to be 11.3% from 2024 to 2031.
What are the major factors driving the precision medicine market growth?
Increasing technological advancements and growing prevalence of chronic diseases are the major factor driving the growth of the precision medicine market.
What are the key factors hampering the growth of the precision medicine market?
Complex data integration & analysis and high cost of genomic testing and data storage are the major factors hampering the growth of the precision medicine market.
Which is the leading application in the precision medicine market?
In terms of application, oncology is estimated to dominate the market revenue share in 2024.
Which are the major players operating in the precision medicine market?
Intomics, GENinCode, NanoString, Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc, QIAGEN, Quest Diagnostics Incorporated, Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, bioMérieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly & Company, GlaxoSmithKline plc, Cepheid, AstraZeneca PLC, Myriad Genetics Inc., and Bristol-Myers Squibb Company are the major players operating in the market.
Which region will lead the precision medicine market?
North America is expected to lead the precision medicine market.